KR20240036213A - Baby bottom cleanser composition Composition comprising ginger and herbal extract for anti-bacteria - Google Patents
Baby bottom cleanser composition Composition comprising ginger and herbal extract for anti-bacteria Download PDFInfo
- Publication number
- KR20240036213A KR20240036213A KR1020220114704A KR20220114704A KR20240036213A KR 20240036213 A KR20240036213 A KR 20240036213A KR 1020220114704 A KR1020220114704 A KR 1020220114704A KR 20220114704 A KR20220114704 A KR 20220114704A KR 20240036213 A KR20240036213 A KR 20240036213A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- antibacterial
- ginger
- baby
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 28
- 241000234314 Zingiber Species 0.000 title claims abstract description 22
- 235000006886 Zingiber officinale Nutrition 0.000 title claims abstract description 22
- 235000008397 ginger Nutrition 0.000 title claims abstract description 22
- 239000012676 herbal extract Substances 0.000 title abstract description 8
- 239000000284 extract Substances 0.000 claims abstract description 115
- 239000002537 cosmetic Substances 0.000 claims abstract description 19
- 241000186660 Lactobacillus Species 0.000 claims abstract description 17
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 17
- 230000000843 anti-fungal effect Effects 0.000 claims abstract description 13
- 238000000855 fermentation Methods 0.000 claims abstract description 13
- 230000004151 fermentation Effects 0.000 claims abstract description 13
- 239000000706 filtrate Substances 0.000 claims abstract description 13
- 239000001366 lippia graveolens leaf Substances 0.000 claims abstract description 6
- 241000222122 Candida albicans Species 0.000 claims description 8
- 241000588724 Escherichia coli Species 0.000 claims description 8
- 229940095731 candida albicans Drugs 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 230000001172 regenerating effect Effects 0.000 claims description 6
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 5
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 5
- 229940121375 antifungal agent Drugs 0.000 claims description 5
- 241000207201 Gardnerella vaginalis Species 0.000 claims description 4
- 241000191967 Staphylococcus aureus Species 0.000 claims description 4
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 229940092385 radish extract Drugs 0.000 claims description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 abstract description 3
- 230000008929 regeneration Effects 0.000 abstract description 3
- 238000011069 regeneration method Methods 0.000 abstract description 3
- 241000427159 Achyranthes Species 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 238000009472 formulation Methods 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 9
- 238000000605 extraction Methods 0.000 description 7
- -1 pack Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 210000004927 skin cell Anatomy 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 235000013628 Lantana involucrata Nutrition 0.000 description 4
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 240000007673 Origanum vulgare Species 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 229940002508 ginger extract Drugs 0.000 description 4
- 235000020708 ginger extract Nutrition 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229940015975 1,2-hexanediol Drugs 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 229940073499 decyl glucoside Drugs 0.000 description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 3
- 239000008361 herbal raw material Substances 0.000 description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000003367 anti-collagen effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 229940080421 coco glucoside Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000000774 hypoallergenic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000006872 mrs medium Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010016275 Fear Diseases 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
- 241001468157 Lactobacillus johnsonii Species 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000006243 Oenanthe sarmentosa Species 0.000 description 1
- 235000004199 Oenanthe sarmentosa Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 235000003828 Sium suave Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 108010030694 avidin-horseradish peroxidase complex Proteins 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- HOWJQLVNDUGZBI-UHFFFAOYSA-N butane;propane Chemical compound CCC.CCCC HOWJQLVNDUGZBI-UHFFFAOYSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- 229940096422 collagen type i Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005370 electroosmosis Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 229940054346 lactobacillus helveticus Drugs 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940117336 parsley extract Drugs 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000003817 vacuum liquid chromatography Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/591—Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 생강 및 허브 추출물을 함유하는 항균용 아기 엉덩이 청결제 조성물에 관한 것으로서, 상기 조성물에는 생강 초임계 추출물, 오레가노 잎 추출물, 무환자 추출물, 약모밀 추출물 및 락토바실러스 발효 여과물이 복합적으로 포함되어, 각각의 단일 추출물에 비해 항균 및 항진균성이 뛰어나고 우수한 세정력을 갖는다.
또한 피부 진정, 재생 등의 복합기능성을 가져 다양한 용도의 화장료 조성물로 용이하게 이용할 수 있다. The present invention relates to an antibacterial baby's butt cleaner composition containing ginger and herb extract, wherein the composition contains a combination of ginger supercritical extract, oregano leaf extract, achyranthes extract, herbal extract, and Lactobacillus fermentation filtrate, respectively. It has excellent antibacterial and antifungal properties and excellent cleaning power compared to the single extract of .
In addition, it has multiple functionalities such as skin soothing and regeneration, so it can be easily used as a cosmetic composition for various purposes.
Description
본 발명은 생강 및 허브 추출물을 함유하는 항균용 아기 엉덩이 청결제 조성물에 관한 것이다. The present invention relates to an antibacterial baby butt cleaner composition containing ginger and herb extract.
피부는 외부 환경에 직접적으로 노출되는 신체 부위로서, 우리 몸의 중요한 기관들을 보호하는 보호막 역할을 할 뿐만 아니라 수분 증발을 조절하고 외부 감염으로부터 몸을 보호하는 역할을 한다. 한편 최근 개발되는 신체 세정제들은 각종 바이러스나 감염성 질환 등에 대한 공포로 인해 항균과 세정력에만 치우친 나머지 단시간의 세정효과를 증강시키는 것에 주로 집중하곤 하였다. 이를 위해 보다 강한 화학계면활성제, 원료 절감을 위한 화학방부제, 인공향료, 인공 색소 등이 첨가되어, 유수분 밸런스가 깨지고 작열감을 유발하거나 각질을 필요 이상 제거함으로써 피부를 외부 감염에 더 취약하게 하기도 한다. The skin is a part of the body that is directly exposed to the external environment. It not only acts as a protective layer to protect the important organs of our body, but also regulates moisture evaporation and protects the body from external infections. Meanwhile, recently developed body cleansers have focused only on antibacterial and cleansing properties due to fears about various viruses and infectious diseases, and have mainly focused on enhancing the short-term cleansing effect. To this end, stronger chemical surfactants, chemical preservatives to reduce raw materials, artificial fragrances, and artificial colors are added, which breaks the oil-water balance, causes a burning sensation, or removes more dead skin cells than necessary, making the skin more vulnerable to external infections.
따라서 피부가 민감한 유아, 사춘기의 청소년, 아토피 등을 겪는 어린이나 성인 등의 경우, 약한 피부에 맞게 저자극성, 무자극성 제품에 대한 선호도가 나날이 증가하고도 있다. 그렇지만, 저자극 원료의 사용시 최종 제품에서의 경제성이 좋지 않거나, 천연물의 한계일 수도 있지만, 제조 당시 위생 상태 등으로 인해 사용품질이 늘 동일하게 보장되지 않을 수 있어 그 사용이 제한되기도 한다. Therefore, in the case of infants with sensitive skin, teenagers in puberty, children and adults suffering from atopy, etc., the preference for hypoallergenic and non-irritating products suitable for sensitive skin is increasing day by day. However, when using hypoallergenic raw materials, the economic feasibility of the final product may be poor, or it may be a limitation of natural products, and the quality may not always be guaranteed the same due to sanitary conditions at the time of manufacture, so their use may be limited.
이에 본 발명자들은 화학계면활성제, 화학방부제, 인공향료, 인공색소를 포함하지 않고도 다양한 허브 추출물을 혼합 적용하는 방법을 이용함으로써, 이를 인체 세정제에 도입하여 항균이나 항진균 활성이 우수하면서도 피부 부작용이 미미하고 피부 진정, 보습, 재생 등의 효과를 낼 수 있는 최적의 아기 엉덩이 청결제 조성물을 제조함으로써 본 발명을 완성하게 되었다. Accordingly, the present inventors used a method of mixing and applying various herbal extracts without including chemical surfactants, chemical preservatives, artificial fragrances, and artificial pigments, and introduced them into human body cleansers to provide excellent antibacterial and antifungal activity while having minimal skin side effects. The present invention was completed by manufacturing an optimal baby butt cleaner composition that can produce skin soothing, moisturizing, and regenerative effects.
본 발명의 목적은 생강 및 허브 추출물을 함유하는 항균용 아기 엉덩이 청결제 조성물을 제공하는 데에 있다. The purpose of the present invention is to provide an antibacterial baby butt cleaner composition containing ginger and herb extract.
본 발명은 생강 및 허브 추출물을 함유하는 항균용 아기 엉덩이 청결제 조성물에 관한 것이다. The present invention relates to an antibacterial baby butt cleaner composition containing ginger and herb extract.
바람직하게는 상기 생강 및 허브 추출물은, 생강 초임계 추출물, 오레가노 잎 추출물, 무환자 추출물, 약모밀 추출물 및 락토바실러스 발효 여과물의 혼합 추출물일 수 있다. 더 바람직하게는 상기 추출물은 생강 초임계 추출물 100 중량부 기준으로, 오레가노 잎 추출물 5~30 중량부, 무환자 추출물 2500~2800 중량부, 약모밀 추출물 1000~1700 중량부 및 락토바실러스 발효 여과물 5~30 중량부가 혼합된 것일 수 있다. Preferably, the ginger and herb extract may be a mixed extract of ginger supercritical extract, oregano leaf extract, radish extract, medicinal buckwheat extract, and Lactobacillus fermentation filtrate. More preferably, the extract is based on 100 parts by weight of ginger supercritical extract, 5 to 30 parts by weight of oregano leaf extract, 2,500 to 2,800 parts by weight of sterile extract, 1,000 to 1,700 parts by weight of herbal extract, and 5 to 30 parts by weight of Lactobacillus fermentation filtrate. Parts by weight may be mixed.
상기 바람직하게는 추출물은 대장균(Escherichia coli), 포도상구균(Staphylococcus aureus) 또는 가드넬라 바기날리스(Gardnerella vaginalis)에 대한 항균 효능이 있는 것일 수 있다. Preferably, the extract may have antibacterial effect against Escherichia coli , Staphylococcus aureus , or Gardnerella vaginalis .
상기 추출물은 항진균 효능이 있는 것일 수 있다. 바람직하게는 칸다다 알비칸스(Candida albicans)에 대한 항진균 효능이 있는 것을 특징으로 한다. The extract may have antifungal efficacy. Preferably, it is characterized by antifungal efficacy against Candida albicans .
상기 추출물은 피부 진정 효능이 있으며, 또한 상기 추출물은 피부 재생 효능이 있는 것일 수 있다. The extract may have a skin soothing effect, and the extract may also have a skin regenerative effect.
이에 본 발명은 상기 조성물을 함유하는 항균, 항진균, 피부 진정 또는 피부 재생 효능이 있는 화장료 조성물에 관한 것일 수 있다. Accordingly, the present invention may relate to a cosmetic composition containing the above composition and having antibacterial, antifungal, skin soothing, or skin regenerative effects.
상기 생강 초임계 추출물은 생강 분말을 초임계 이산화탄소를 이용하여 35~55℃의 온도, 100~400 bar의 압력에서 1~3mL/min의 유속으로 1~3 시간 동안 초임계 추출법으로 추출한 것일 수 있다. 이 추출법을 통해 2.5~3.0중량%의 수율로 오일 상태의 생강 초임계 추출물을 얻을 수 있다. The ginger supercritical extract may be extracted by supercritical extraction of ginger powder using supercritical carbon dioxide at a temperature of 35 to 55°C and a pressure of 100 to 400 bar at a flow rate of 1 to 3 mL/min for 1 to 3 hours. . Through this extraction method, oil-like supercritical ginger extract can be obtained with a yield of 2.5 to 3.0% by weight.
상기 생강 분말은 평균 입도가 50~500㎛일 수 있다.The ginger powder may have an average particle size of 50 to 500 μm.
본 발명에서 추출물 제조에 이용되는 허브는 오레가노 잎, 무환자, 약모밀을 포함한다. Herbs used in the preparation of extract in the present invention include oregano leaves, radish, and herbal medicine.
본 발명의 추출물에는 락토바실러스 발효 여과물이 혼합되어 포함될 수 있다. 상기 락토바실러스 발효물은 락토바실러스 균체를 초음파 처리하여 얻은 액상일 수 있다. 보다 바람직하게는 MRS 배지에 배양된 락토바실러스 속 균주의 배양액을 원심분리하여 얻은 균주 균체를 10~20배 중량의 증류수에 희석하여 초음파 처리 후, 동일한 조건으로 추가적으로 원심분리 후 액상을 수득하여 여과한 것일 수 있다. 상기 초음파는 35~39kHz의 세기의 초음파를 생성하는 울트라소니케이터를 이용하여 5~15분간 처리할 수 있다. 상기 각각의 원심분리는 2~5℃, 1000~15000rpm에서 10~30분 동안 수행할 수 있다. 두 번째 원심분리하여 얻은 액상을 막필터를 이용하여 여과할 수 있다. 상기 막필터는 기공크기 0.1 ~ 10 μm의 여과막을 가진 것일 수 있다. The extract of the present invention may include a mixture of Lactobacillus fermentation filtrate. The Lactobacillus fermented product may be a liquid obtained by sonicating Lactobacillus cells. More preferably, the strain cells obtained by centrifuging the culture medium of Lactobacillus strains cultured in MRS medium are diluted with 10 to 20 times the weight of distilled water, sonicated, and further centrifuged under the same conditions to obtain a liquid and filtered. It may be. The ultrasonic waves can be processed for 5 to 15 minutes using an ultrasonicator that generates ultrasonic waves with an intensity of 35 to 39 kHz. Each of the above centrifugations can be performed at 2 to 5°C and 1000 to 15000 rpm for 10 to 30 minutes. The liquid obtained from the second centrifugation can be filtered using a membrane filter. The membrane filter may have a filtration membrane with a pore size of 0.1 to 10 μm.
상기 락토바실러스 속 균주는 락토바실러스 아시도필루스(Lactobacillus acidophilus), 락토바실러스 불가리쿠스 (Lactobacillus bulgaricus), 락토바실러스 파라카세이(Lactobacillus paracasei),토바실러스 카세이(Lactobacillus casei), 락토바실러스 퍼멘텀(Lactobacillus fermentum), 락토바실러스 가세리(Lactobacillus gasseri), 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 락토바실러스 람노서스(Lactobacillus rhamnosus), 락토바실러스 존소니이(Lactobacillus johnsonii), 락토바실러스 플란타룸(Lactobacillus plantarum) 및 락토바실러스 루테리(Lactobacillus reuteri)에서 선택될 수 있다. The Lactobacillus genus strains include Lactobacillus acidophilus, Lactobacillus bulgaricus , Lactobacillus paracasei , Lactobacillus casei , and Lactobacillus fermentum . ), Lactobacillus gasseri , Lactobacillus helveticus, Lactobacillus rhamnosus , Lactobacillus johnsonii , Lactobacillus plantarum and lactobacillus It may be selected from Bacillus reuteri ( Lactobacillus reuteri ).
상기 각각의 허브 추출물은 허브 원료를 물, C1~C4 알코올 또는 이들의 혼합용액을 용매로 하여 추출할 수 있다. 상기 C1~C4 알코올은 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 및 이소부탄올로 이루어진 군에서 선택될 수 있다. 바람직하게는 상기 추출물은 알코올 수용액을 용매로 하여 추출한 것일 수 있다. 더 바람직하게는 50~80%(v/v) 알코올 수용액일 수 있으며, 가장 바람직하게는 50~80%(v/v) 에탄올 수용액일 수 있다. Each of the above herbal extracts can be extracted from herbal raw materials using water, C1 to C4 alcohol, or a mixed solution thereof as a solvent. The C1 to C4 alcohol may be selected from the group consisting of methanol, ethanol, propanol, isopropanol, butanol, and isobutanol. Preferably, the extract may be extracted using an aqueous alcohol solution as a solvent. More preferably, it may be a 50-80% (v/v) alcohol aqueous solution, and most preferably, it may be a 50-80% (v/v) ethanol aqueous solution.
상기 허브 추출물의 제조시 사용되는 물, C1~C4 알코올 또는 이들의 혼합용액은 허브 사용 중량 기준 1~40배 부피(1kg 기준 1~40ℓ)를 사용할 수 있으며, 바람직하게는 5~40배 부피를 사용할 수 있다. 상기 허브 추출물의 추출조건은 20~100℃에서 1분~48시간일 수 있다. 상기 과정은 1~4번까지 반복할 수 있다. Water, C1 to C4 alcohol, or a mixed solution thereof used in the production of the herbal extract can be used in an amount of 1 to 40 times the volume (1 to 40 liters per kg) based on the weight of the herb used, and preferably 5 to 40 times the volume. You can use it. Extraction conditions for the herbal extract may be 1 minute to 48 hours at 20 to 100°C. The above process can be repeated 1 to 4 times.
또한, 당분야의 통상적인 방법으로서 상기 허브 원료의 물, C1~C4 알코올 또는 이들의 혼합용액 추출물을 물에 녹인 후에 n-헥산, 메틸렌클로라이드, 아세톤, 클로로포름, 에틸아세테이트 및 n-부탄올로 이루어진 군 중에서 선택되는 1종 이상의 용매를 사용하여 추가적으로 분획하여 분획물로 제조할 수 있다. In addition, as a common method in the art, the extract of water, C1 to C4 alcohol, or a mixture thereof of the herbal raw material is dissolved in water, and then a group consisting of n-hexane, methylene chloride, acetone, chloroform, ethyl acetate, and n-butanol. It can be prepared as a fraction by additional fractionation using one or more solvents selected from among.
상기 추출물 또는 이의 분획물의 제조온도는 20 내지 100℃일 수 있으나, 이에 제한되는 것은 아니다. 추출 또는 분획 시간은 특별히 제한되는 것은 아니나, 10분 내지 2일 이내에 추출하는 것이 바람직하며, 추출용 기기로는 통상의 추출기기, 초음파분쇄추출기 또는 분획기를 이용할 수 있다. 이렇게 제조된 추출물 또는 분획물은 열풍건조, 감압건조 또는 동결건조하여 용매를 제거할 수 있다. 용매가 제거된 추출물 또는 분획물은 각각 부틸렌글리콜 또는 이의 수용액에 용해하여 화장료에 적용될 수 있다. 이 때 글리세린이 더 포함될 수도 있다. The production temperature of the extract or fraction thereof may be 20 to 100° C., but is not limited thereto. The extraction or fractionation time is not particularly limited, but is preferably extracted within 10 minutes to 2 days, and the extraction device may be a conventional extraction device, an ultrasonic grinding extractor, or a fractionator. The extract or fraction prepared in this way can be dried with hot air, dried under reduced pressure, or freeze-dried to remove the solvent. The extract or fraction from which the solvent has been removed can be dissolved in butylene glycol or its aqueous solution and applied to cosmetics. At this time, more glycerin may be included.
또한, 상기 추출물 또는 분획물은 컬럼크로마토그래피를 이용하여 정제하여 사용할 수 있다. Additionally, the extract or fraction can be purified and used using column chromatography.
상기 크로마토그래피는 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 엘에이취-20 컬럼 크로마토그래피(LH-20 column chromatography), 이온교환수지 크로마토그래피(ion exchange resin chromatography), 중압 액체 크로마토그래피(medium pressure liquid chromatography), 박층 크로마토그래피(TLC; thin layer chromatography), 실리카겔 진공 액체 크로마토그래피(silica gel vacuum liquid chromatography) 및 고성능 액체 크로마토그래피(high performance liquid chromatography) 중에서 선택될 수 있다. The chromatography includes silica gel column chromatography, LH-20 column chromatography, ion exchange resin chromatography, and medium pressure liquid chromatography. chromatography), thin layer chromatography (TLC), silica gel vacuum liquid chromatography, and high performance liquid chromatography.
상기 화장료 조성물의 제형으로는 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 에센스, 로션, 에멀젼, 팩, 핸드크림, 풋크림, 립밤, 립스틱, 아이섀도우, 아이라이너, 아이브로우 펜슬, 블러셔, 하이라이터, 일반화장수, 스킨, 크림, 세럼, 미용비누, 유연화장수, 약용화장수, 전신세정제, 클렌징폼, 클렌징로션, 겔, 클렌징 오일, 클렌징 크림, 샴푸, 린스, 헤어트리트먼트, 헤어로션, 클렌징 티슈 및 클렌징 워터에서 선택되는 것을 제공할 수 있다. The formulation of the cosmetic composition may be any formulation commonly manufactured in the art, including essence, lotion, emulsion, pack, hand cream, foot cream, lip balm, lipstick, eye shadow, eyeliner, and eyebrow pencil. , blusher, highlighter, general lotion, skin, cream, serum, beauty soap, softening lotion, medicated lotion, body cleanser, cleansing foam, cleansing lotion, gel, cleansing oil, cleansing cream, shampoo, conditioner, hair treatment, hair You can provide a selection from lotions, cleansing tissues and cleansing water.
보다 더 자세하게는, 본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다. 본 발명의 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판-부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다. 본 발명의 화장료 조성물의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다. 본 발명의 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다. 본 발명의 화장료 조성물의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 아세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다. 본 발명의 화장료 조성물은 형광물질, 살진균제, 굴수성 유발물질, 보습제, 방향제, 방향제 담체, 단백질, 용해화제, 당 유도체, 일광차단제, 비타민, 식물 추출물 등을 포함하는 부형제를 추가로 함유할 수 있다. 상기 성분들은 제형 또는 사용목적에 따라 그 첨가량을 화장료 조성물 고유의 효과를 손상시키지 않는 범위 내에서 선택할 수 있다. 상기 성분들의 첨가량은 예를 들어 조성물 총 중량에 대하여 0.1~10 중량%, 바람직하게는 0.1~6 중량%일 수 있으나 이에 제한되는 것은 아니다.More specifically, when the formulation of the cosmetic composition of the present invention is a paste, cream or gel, animal fiber, plant fiber, wax, paraffin, starch, tragacanth, cellulose derivative, polyethylene glycol, silicone, bentonite, and silica are used as carrier ingredients. , talc or zinc oxide can be used. When the formulation of the cosmetic composition of the present invention is powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, or polyamide powder can be used as the carrier ingredient. In particular, when the cosmetic composition is a spray, chlorofluorohydride may be used as a carrier ingredient. It may contain propellants such as carbon, propane-butane or dimethyl ether. When the formulation of the cosmetic composition of the present invention is a solution or emulsion, a solvent, solvating agent or emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene. These include fatty acid esters of glycol, 1,3-butylglycol oil, glycerol aliphatic esters, polyethylene glycol or sorbitan. When the formulation of the cosmetic composition of the present invention is a suspension, the carrier component includes water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, and polyoxyethylene sorbitan ester, Microcrystalline cellulose, aluminum metahydroxide, bentonite, agar, or tracant may be used. When the formulation of the cosmetic composition of the present invention is a surfactant-containing cleansing agent, the carrier ingredients include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, acethionate, imidazolinium derivative, methyl taurate, and sarcosinate. , fatty acid amide ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, linoline derivative, or ethoxylated glycerol fatty acid ester can be used. The cosmetic composition of the present invention may further contain excipients including fluorescent substances, fungicides, hydrotropes-inducing substances, moisturizers, fragrances, fragrance carriers, proteins, solubilizers, sugar derivatives, sunscreens, vitamins, plant extracts, etc. . The amount of the above ingredients can be selected depending on the formulation or purpose of use within a range that does not impair the inherent effect of the cosmetic composition. The amount of the ingredients added may be, for example, 0.1 to 10% by weight, preferably 0.1 to 6% by weight, based on the total weight of the composition, but is not limited thereto.
본 발명의 아기 엉덩이 청결제는 또한 바람직하게는 상기 생강 및 허브 추출물의 혼합 추출물, 1,2-헥산디올, 다이소듐 EDTA, 하이드록시에틸셀룰로오스, 코코글루코사이드, 데실글루코사이드를 포함할 수 있다. 보다 바람직하게는 상기 생강 및 허브 추출물의 혼합 추출물 1~5 중량%, 1,2-헥산디올 0.0001~0.1 중량%, 다이소듐 EDTA 0.001~0.1 중량%, 하이드록시에틸셀룰로오스 1~3 중량%, 코코글루코사이드 0.1~2 중량%, 데실글루코사이드 0.1~1 중량%를 포함할 수 있다. The baby butt cleaner of the present invention may also preferably include a mixed extract of the above ginger and herb extracts, 1,2-hexanediol, disodium EDTA, hydroxyethylcellulose, cocoglucoside, and decylglucoside. More preferably, 1 to 5% by weight of the mixed extract of the ginger and herb extract, 0.0001 to 0.1% by weight of 1,2-hexanediol, 0.001 to 0.1% by weight of disodium EDTA, 1 to 3% by weight of hydroxyethylcellulose, and cocoa. It may contain 0.1 to 2% by weight of glucoside and 0.1 to 1% by weight of decylglucoside.
본 발명은 생강 및 허브 추출물을 함유하는 항균용 아기 엉덩이 청결제 조성물에 관한 것으로서, 상기 조성물에는 생강 초임계 추출물, 오레가노 잎 추출물, 무환자 추출물, 약모밀 추출물 및 락토바실러스 발효 여과물이 복합적으로 포함되어, 각각의 단일 추출물에 비해 항균 및 항진균성이 뛰어나고 우수한 세정력을 갖는다. 또한 피부 진정, 재생 등의 복합기능성을 가져 다양한 용도의 화장료 조성물로 용이하게 이용할 수 있다. The present invention relates to an antibacterial baby's butt cleanser composition containing ginger and herb extract, wherein the composition contains a combination of ginger supercritical extract, oregano leaf extract, Amurium extract, medicinal root extract, and Lactobacillus fermentation filtrate, respectively. It has excellent antibacterial and antifungal properties and excellent cleaning power compared to the single extract of . In addition, it has multiple functionalities such as skin soothing and regeneration, so it can be easily used as a cosmetic composition for various purposes.
이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 그러나, 본 발명은 여기서 설명되는 실시예에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 내용이 철저하고 완전해지도록, 당업자에게 본 발명의 사상을 충분히 전달하기 위해 제공하는 것이다. Hereinafter, preferred embodiments of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms. Rather, it is provided to ensure that the content introduced here is thorough and complete, and to sufficiently convey the spirit of the present invention to those skilled in the art.
<제조예 1. 생강 초임계 추출물의 제조><Preparation Example 1. Preparation of supercritical ginger extract>
초임계유체추출장치(SFT-100XW, Supercritical Fluid Technologies, Inc., Newark, DE, USA)를 사용하여, 평균입도가 50 ~ 500 ㎛인 생강 분말 18g을 100 mL의 용량의 추출조에 넣어 추출하였다. 시료의 추출조건은 45℃에서 100bar로 압력을 유지하여 실시하였고, 이산화탄소의 유속은 2 mL/min로 다이나믹 모드에서 2시간 동안 추출하여 추출물을 곧바로 용기(vial)에 받아내었다. 수득된 생강 추출물은 감압농축하여 필요에 따라 부틸렌글라이콜 또는 이의 수용액에 용해하여 사용하였다. Using a supercritical fluid extraction device (SFT-100XW, Supercritical Fluid Technologies, Inc., Newark, DE, USA), 18 g of ginger powder with an average particle size of 50 to 500 ㎛ was extracted by placing it in a 100 mL extraction tank. The sample extraction conditions were conducted at 45°C and pressure maintained at 100 bar, and the carbon dioxide flow rate was 2 mL/min for 2 hours in dynamic mode, and the extract was immediately placed in a vial. The obtained ginger extract was concentrated under reduced pressure and, if necessary, dissolved in butylene glycol or its aqueous solution for use.
<제조예 2. 허브 추출물 및 락토바실러스 발효 여과물 제조><Preparation Example 2. Preparation of herbal extract and Lactobacillus fermentation filtrate>
오레가노 잎 추출물, 무환자 추출물, 약모밀 추출물 및 락토바실러스 발효 여과물을 제조하였다. Oregano leaf extract, radish extract, Yammil extract, and Lactobacillus fermentation filtrate were prepared.
이를 위해, 오레가노 잎, 무환자, 약모밀 각 허브 원료는 건조된 상태로 구입하여 10배 중량의 70%(v/v) 에탄올 수용액에 침지한 후 70℃에서 24시간 동안 두고, 액상만을 얻고 감압농축하여 추출물 상태로 제조하였다. 이 후 필요에 따라 부틸렌글라이콜 또는 이의 수용액에 용해하여 사용하였다. For this purpose, each herbal raw material such as oregano leaves, radish, and medicinal buckwheat was purchased in a dried state, immersed in 10 times the weight of 70% (v/v) ethanol aqueous solution, left at 70°C for 24 hours, and only the liquid phase was obtained and concentrated under reduced pressure. It was prepared in extract form. Afterwards, it was used by dissolving it in butylene glycol or its aqueous solution as needed.
락토바실러스 발효 여과물의 제조를 위해서는 먼저, 통상적인 유제품 발효용 락토바실러스 플란타룸 균주를 구입하여 MRS 배지에서 배양하였다. 이 후, 배양액을 4℃, 10000rpm에서 20분 동안 원심분리하여 균체를 수득한 후, 상기 균체를 10배 중량의 증류수에 희석하여 울트라소니케이터(37kHz)를 이용하여 10분간 초음파 처리하였다. 초음파 처리후에는 다시 같은 조건으로 4℃, 10000rpm에서 20분 동안 원심분리하고, 액상을 수거하여 2 μm의 여과막으로 여과하여 락토바실러스 발효 여과물을 얻었다. 얻은 여과물은 감압농축하였고, 이 후 필요에 따라 부틸렌글라이콜 또는 이의 수용액에 용해하여 사용하였다. To prepare Lactobacillus fermentation filtrate, first, a Lactobacillus plantarum strain for typical dairy fermentation was purchased and cultured in MRS medium. Afterwards, the culture medium was centrifuged at 4°C and 10,000 rpm for 20 minutes to obtain bacterial cells, and then the bacterial cells were diluted with 10 times the weight of distilled water and sonicated for 10 minutes using an ultrasonicator (37 kHz). After sonication, centrifugation was performed again at 4°C and 10,000 rpm for 20 minutes under the same conditions, and the liquid was collected and filtered through a 2 μm filtration membrane to obtain Lactobacillus fermentation filtrate. The obtained filtrate was concentrated under reduced pressure and then used by dissolving in butylene glycol or its aqueous solution as needed.
<실시예 1 내지 5><Examples 1 to 5>
하기 표 1의 조건으로 각 원료를 혼합하고 이를 10배 중량의 30%(v/v) 부틸렌글라이콜 수용액에 용해하였다. Each raw material was mixed under the conditions in Table 1 below and dissolved in 10 times the weight of a 30% (v/v) butylene glycol aqueous solution.
추출물 (g)ginger supercritical
Extract (g)
추출물 (g)oregano leaves
Extract (g)
추출물 (g)no patient
Extract (g)
추출물 (g)Weak buckwheat
Extract (g)
발효 여과물 (g)Lactobacillus
Fermentation filtrate (g)
(g)total
(g)
<비교예 1 내지 5><Comparative Examples 1 to 5>
하기 표 2의 조건으로 각 원료를 혼합하고 이를 10배 중량의 30%(v/v) 부틸렌글라이콜 수용액에 용해하였다. Each raw material was mixed under the conditions in Table 2 below and dissolved in 10 times the weight of a 30% (v/v) butylene glycol aqueous solution.
추출물 (g)ginger supercritical
Extract (g)
추출물 (g)oregano leaves
Extract (g)
추출물 (g)no patient
Extract (g)
추출물 (g)Weak buckwheat
Extract (g)
발효 여과물 (g)Lactobacillus
Fermentation filtrate (g)
(g)total
(g)
<실험예 1. 항균/항진균 효능 확인><Experimental Example 1. Confirmation of antibacterial/antifungal efficacy>
항균 활성 검정은 RDA (radial diffusion assay) 실험 방법을 이용하여 확인하였다. RDA법은 Citrate phosphate buffer(9 mM sodium phosphate, 1 mM sodium citrate, pH7.4)와 1%(w/v) type Ⅰ(low electroendosmosis) agarose, 0.03% TSB로 구성된 멸균된 underlay gel에 배양된 세균 (4 × 106colony forming units)을 넣고 혼합해준 뒤 사각플레이트에 붓고, underlay gel이 굳으면 지름 3mm의 구멍을 내어 각 추출물을 100㎍이 최종농도가 되도록 5 ㎕씩 구멍에 loading 하였다. 각 추출물이 균일하게 확산되도록 37℃에서 3시간 배양한 후, overlay agar(6% TSB, 1% agarose) 10 ㎖을 붓고 37℃에서 다시 배양하여 clear zone을 확인하고 직경을 측정하였다. 균주 사용은 Escherichia coli, Staphylococcus aureus, Gardnerella vaginalis, 진균은 Candida albicans를 대표로 사용하였다. 이에 대한 결과는 표 3에 나타내었다.Antibacterial activity was confirmed using the RDA (radial diffusion assay) test method. The RDA method involves culturing bacteria on a sterilized underlay gel consisting of citrate phosphate buffer (9 mM sodium phosphate, 1 mM sodium citrate, pH 7.4), 1% (w/v) type Ⅰ (low electroendosmosis) agarose, and 0.03% TSB. ( 4 After cultivating each extract for 3 hours at 37°C to ensure uniform diffusion, 10 ml of overlay agar (6% TSB, 1% agarose) was poured and cultured again at 37°C to confirm the clear zone and measure the diameter. The representative strains used were Escherichia coli , Staphylococcus aureus , and Gardnerella vaginalis, and the fungi used were Candida albicans . The results are shown in Table 3.
표 3을 참고하면, 본 발명의 실시예 1 내지 5의 추출물이 실험한 모든 세균 또는 진균에 대해 항균/항진균 효과가 있었다.Referring to Table 3, the extracts of Examples 1 to 5 of the present invention had antibacterial/antifungal effects against all bacteria or fungi tested.
<실험예 3. 피부 진정 효능 확인><Experimental Example 3. Confirmation of skin soothing effect>
60 mm culture dish (corning)에 인간각질형성세포(human keratinocyte, HaCaT)를 배양한 뒤 HBSS (Hank's Balanced Salt Solution, Gibco) 하에서 세포자극원으로 H2O2 250μM 를 1시간 처리하였다. 이 때, H2O2가 피부 세포의 염증 유발 및 장벽 기능 손실을 일으키게 되면서 사람의 피부에 홍반이나 접촉성 피부염 등을 일으키는 원리와 같은 작용을 하게 된다. Human keratinocytes (HaCaT) were cultured in a 60 mm culture dish (corning) and then treated with 250 μM H 2 O 2 as a cell stimulant in HBSS (Hank's Balanced Salt Solution, Gibco) for 1 hour. At this time, H 2 O 2 It causes inflammation of skin cells and loss of barrier function, acting in the same way as causing erythema or contact dermatitis on human skin.
배지 교체 후, 추출물 시료를 24시간 처리하였고, QIAzol™ Lysis Reagent (Qiagen) 로 모아 RNA를 분리하였으며, Real-time PCR을 실시하였다. 이 때 최종 추출물의 처리 농도는 100 ㎍/㎖ 였다. After replacing the medium, the extract samples were treated for 24 hours, RNA was isolated using QIAzol™ Lysis Reagent (Qiagen), and real-time PCR was performed. At this time, the treatment concentration of the final extract was 100 μg/ml.
실험 결과, 표 4와 같이 본 발명의 추출물 처리군에서 IL-Iα와 IL-6 유전자 발현량이 현저하게 억제되는 것을 확인할 수 있어, H2O2 로 자극된 피부세포의 진정 효과가 있는 것을 확인할 수 있다. As a result of the experiment, as shown in Table 4, it was confirmed that the expression levels of IL-Iα and IL-6 genes were significantly suppressed in the group treated with the extract of the present invention, confirming that there was a soothing effect on skin cells stimulated by H 2 O 2 there is.
이 실험은 세포 자극원으로 UVB 50 mJ/㎠을 처리하여 반복적으로 실시하여서도 비슷한 결과를 얻을 수 있었다. Similar results were obtained even when this experiment was repeatedly conducted using 50 mJ/cm2 of UVB as a cell stimulator.
<실험예 4. 피부 재생 효능 확인><Experimental Example 4. Confirmation of skin regeneration efficacy>
본 발명에서 제조한 각 추출물에 대해 피부 세포의 재생에 가장 많은 영향을 주는 콜라겐 type I, IV 합성에 미치는 효과를 측정하기 위해서, 하기와 같이 실험을 진행하였다. In order to measure the effect of each extract prepared in the present invention on the synthesis of collagen types I and IV, which have the greatest influence on the regeneration of skin cells, an experiment was conducted as follows.
96 well microtiter plate에 monoclonal anti-collagen I 또는 IV Anti-body(2 μg/well/PBS)를 주입 후 12시간 동안 상온에서 코팅하였다. Blocking buffer로 상온에서 1시간 동안 blocking 후, 각 추출물 시료가 24시간 동안 처리되었던 인간각질형성세포(human keratinocyte, HaCaT)의 배양액(CM)을 well당 100 ㎕씩 처리하여 상온에서 90분 동안 반응시켰다. 각 세포 배양액에 처리된 추출물 시료의 최종 농도는 100 ㎍/㎖였다. 그 후, polyclonal anti-collagen I 또는 IV Anti-body를 각 well에 처리하여 상온에서 90분 동안 반응시킨 다음, avidin-HRP를 각 well에 처리하여 상온에서 60분 동안 반응시켰다.A 96 well microtiter plate was coated at room temperature for 12 hours after injection of monoclonal anti-collagen I or IV Anti-body (2 μg/well/PBS). After blocking with blocking buffer for 1 hour at room temperature, each extract sample was treated with 100 ㎕ of culture medium (CM) of human keratinocyte (HaCaT) treated for 24 hours per well and reacted at room temperature for 90 minutes. . The final concentration of the extract sample treated with each cell culture medium was 100 μg/ml. Afterwards, polyclonal anti-collagen I or IV Anti-body was treated in each well and reacted at room temperature for 90 minutes, and then avidin-HRP was treated in each well and reacted at room temperature for 60 minutes.
Supersignal ELISA pico chemiluminescent substrate를 각 well 당 100 μL 씩 주입하여 10분 동안 반응시킨 후, ELISA plate reader를 이용하여 luminescence 정도를 측정하였고, 각 추출물 처리된 인간각질형성세포(human keratinocyte, HaCaT)의 type I 또는 IV 콜라겐 합성과 분비에 대한 결과를 표 5에 나타내었다. After injecting 100 μL of Supersignal ELISA pico chemiluminescent substrate into each well and reacting for 10 minutes, the degree of luminescence was measured using an ELISA plate reader, and the type I of human keratinocyte (HaCaT) treated with each extract was measured. Alternatively, the results for IV collagen synthesis and secretion are shown in Table 5.
표 5와 같이, 실시예 1 내지 5의 추출물이 세포 내 콜라겐 생합성 효능이 매우 우수함을 확인할 수 있어, 본 발명의 추출물이 피부 세포의 진정과 재생에 탁월한 효능을 주는 아기 엉덩이 청결제 조성물로 이용될 수 있음이 입증된다. As shown in Table 5, it can be confirmed that the extracts of Examples 1 to 5 have very excellent intracellular collagen biosynthesis efficacy, so the extract of the present invention can be used as a baby butt cleanser composition that provides excellent efficacy in soothing and regenerating skin cells. It is proven that there is.
<화장료 조성물 제형 제조 - 아기 엉덩이 청결제 ><Manufacture of cosmetic composition formulation - baby butt cleaner>
실제적으로 활용할 수 있는 제형화를 위해 하기 표 6의 함량으로 각 원료를 혼합하여 아기 엉덩이 청결제를 제조하였다. In order to formulate a formulation that can be used practically, a baby butt cleaner was prepared by mixing each raw material at the content shown in Table 6 below.
또한 하기 표 7과 같이, 각 추출물만 달리하여 표 6의 원료를 함유하는 아기 엉덩이 청결제를 제조하였다. In addition, as shown in Table 7 below, a baby butt cleaner containing the raw materials in Table 6 was prepared by varying only each extract.
<실험예 5. 아기 엉덩이 청결제의 항균성/항진균성 확인><Experimental Example 5. Confirmation of antibacterial/antifungal properties of baby butt cleaner>
본 발명에서 제조한 아기 엉덩이 청결제를 이용하여 항균성과 항진균성을 확인하였다. 겔 제형 전용 펌프 용기에 각 아기 엉덩이 청결제를 충진하였다. 이 후 각 실험은 사람의 손바닥에 동일 부피의 Escherichia coli 및 Candida albicans 배양액을 접촉하게 한 후, 각 용기에서 아기 엉덩이 청결제를 펌핑하여 5mL의 청결제를 덜어 질병관리청의 올바른 손씻기 방법에 따라 손을 세정하였다. 각 군당 실험대상 인원을 5명으로 하였다. Antibacterial and antifungal properties were confirmed using the baby butt cleaner prepared in the present invention. Each baby's butt cleaner was filled into a pump container dedicated to the gel formulation. Afterwards, in each experiment, the same volume of Escherichia coli and Candida albicans culture fluid was placed in contact with the palm of the person's hand, and then the baby's butt cleaner was pumped from each container, 5 mL of the cleaner was taken, and hands were washed according to the proper hand washing method of the Korea Disease Control and Prevention Agency. . The number of experimental subjects in each group was 5.
각 균수는 배양액 접촉 직후와 세정 후로 나누어 측정하였다. 균 수 측정을 위해, 실험대상자의 손바닥을 Escherichia coli 및 Candida albicans 배양용 평판배지에 접촉하게 한 후, 24시간 동안 인큐베이터에서 배양하고 총 균수를 확인하였으며, 세정을 통해 제거된 비율을 하기 표 8에 나타내었다. The number of each bacteria was measured immediately after contact with the culture medium and after washing. To measure the number of bacteria, the palm of the test subject was brought into contact with a plate medium for culturing Escherichia coli and Candida albicans , then cultured in an incubator for 24 hours, and the total number of bacteria was confirmed. The percentage removed through washing is shown in Table 8 below. indicated.
그 결과, 본 발명의 추출물이 함유된 아기 엉덩이 청결제가 Escherichia coli 및 Candida albicans를 매우 효과적으로 제거하여 세정능이 우수함을 확인할 수 있다. As a result, it can be confirmed that the baby butt cleaner containing the extract of the present invention removes Escherichia coli and Candida albicans very effectively and has excellent cleaning ability.
Claims (8)
상기 생강 초임계 추출물은 생강 분말을 초임계 이산화탄소를 이용하여 35~55℃에서, 100~400 bar의 압력에서 1~3mL/min의 유속으로 1~3 시간 동안 초임계 추출법으로 추출한 것을 특징으로 하는 항균용 아기 엉덩이 청결제 조성물. According to paragraph 1,
The ginger supercritical extract is characterized in that ginger powder is extracted by supercritical extraction for 1 to 3 hours at a pressure of 100 to 400 bar at a flow rate of 1 to 3 mL/min at 35 to 55 ° C. using supercritical carbon dioxide. Antibacterial baby butt cleaner composition.
추출물은 대장균(Escherichia coli), 포도상구균(Staphylococcus aureus) 또는 가드넬라 바기날리스(Gardnerella vaginalis)에 대한 항균 효능이 있는 것을 특징으로 하는 항균용 아기 엉덩이 청결제 조성물. According to paragraph 1,
The extract is an antibacterial baby butt cleaner composition characterized in that it has antibacterial effect against Escherichia coli, Staphylococcus aureus , or Gardnerella vaginalis .
상기 추출물은 칸다다 알비칸스(Candida albicans)에 대한 항진균 효능이 있는 것을 특징으로 하는 항균용 아기 엉덩이 청결제 조성물. According to paragraph 1,
The extract is an antibacterial baby butt cleaner composition, characterized in that it has antifungal effect against Candida albicans .
상기 추출물은 피부 진정 효능이 있는 것을 특징으로 하는 항균용 아기 엉덩이 청결제 조성물. According to paragraph 1,
The extract is an antibacterial baby butt cleaner composition characterized in that it has a skin soothing effect.
상기 추출물은 피부 재생 효능이 있는 것을 특징으로 하는 항균용 아기 엉덩이 청결제 조성물. According to paragraph 1,
The extract is an antibacterial baby butt cleaner composition characterized in that it has a skin regenerative effect.
상기 화장료 조성물은 항진균, 피부 진정 또는 피부 재생 효능이 있는 것을 특징으로 하는 항균용 아기 엉덩이 청결제 화장료 조성물. In clause 7,
The cosmetic composition is an antibacterial baby butt cleaner cosmetic composition, characterized in that it has antifungal, skin soothing or skin regenerative effects.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220114704A KR20240036213A (en) | 2022-09-13 | 2022-09-13 | Baby bottom cleanser composition Composition comprising ginger and herbal extract for anti-bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220114704A KR20240036213A (en) | 2022-09-13 | 2022-09-13 | Baby bottom cleanser composition Composition comprising ginger and herbal extract for anti-bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20240036213A true KR20240036213A (en) | 2024-03-20 |
Family
ID=90483416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220114704A KR20240036213A (en) | 2022-09-13 | 2022-09-13 | Baby bottom cleanser composition Composition comprising ginger and herbal extract for anti-bacteria |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20240036213A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100285781B1 (en) | 1998-06-09 | 2001-05-02 | 최영신 | Essential oil composition with antibacterial and antifungal action |
KR101211937B1 (en) | 2012-09-18 | 2012-12-13 | 주식회사 들레네 | Functional fermented wild plants having anti-inflammatory effect using 101 wild plants extracts |
KR101347910B1 (en) | 2012-01-31 | 2014-01-08 | 계명대학교 산학협력단 | a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented |
KR101837020B1 (en) | 2017-02-14 | 2018-03-09 | (주)티이엔 | Separation method for saponins from Sapindus mukorossi and cosmetic composition containing the same |
-
2022
- 2022-09-13 KR KR1020220114704A patent/KR20240036213A/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100285781B1 (en) | 1998-06-09 | 2001-05-02 | 최영신 | Essential oil composition with antibacterial and antifungal action |
KR101347910B1 (en) | 2012-01-31 | 2014-01-08 | 계명대학교 산학협력단 | a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented |
KR101211937B1 (en) | 2012-09-18 | 2012-12-13 | 주식회사 들레네 | Functional fermented wild plants having anti-inflammatory effect using 101 wild plants extracts |
KR101837020B1 (en) | 2017-02-14 | 2018-03-09 | (주)티이엔 | Separation method for saponins from Sapindus mukorossi and cosmetic composition containing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102119825B1 (en) | A cosmetic composition for maintaining the balance of microbiom in the skin comprising brown rice, grean tea and dandelion fermentation extracts and methode thereof | |
KR101998032B1 (en) | Cosmetic Composition for Improving Skin Condition Comprising Rosa Damascena Callus Culture Extract or the fermented filtrates to improve periorbital wrinkles, skin brightness and calm troubled skin | |
KR20130074172A (en) | A composite for cosmetics materals using fermented mater of abelliophyllum distichum | |
KR101917645B1 (en) | Cosmetic composition comprising saccharomyces ferment filtrate, asparagus officinalis stem extract and tussilago farfara flower extract | |
KR20170137963A (en) | A Useful Ferment Extract For Anti-inflammatory Activity And Skin Improvement That Fermented Lettuce, Inula flower And Dandelion With Lactic Acid Bacteria And Cosmetic Composition Including The Same | |
KR102204932B1 (en) | Cosmetic composition with liposome including acerola extract | |
KR102226187B1 (en) | Lactobacillus iners AHC2030 and Fermented Product Manufactured Using Thereof | |
KR20190017084A (en) | Cosmetic composition containing Soybean extracts promoting Ceramide biosynthesis and enhancing Skin Barrier | |
KR102111058B1 (en) | A cosmetic composition for skin moisturizing comprising an extract of plant-derived lactobacillus brevis (ami-1109) femented barley | |
KR101648148B1 (en) | Cosmetic composition containing fermented graviola for improving anti-wrinkle and method of preparing the same | |
KR101990824B1 (en) | Whitening cosmetic composition comprising natural jade mineral and an extract of paper mulberry removing pigment, and method for producing thereof | |
KR20240036213A (en) | Baby bottom cleanser composition Composition comprising ginger and herbal extract for anti-bacteria | |
KR20240036214A (en) | Cleaning composition for girl comprising ginger and complex extract having anti-fungi | |
KR102594733B1 (en) | Cosmetic composition for improving melasma, freckles, whitenings and wrinkle comprising extract of fermented chestnut inner shell, angelica dahurica, portulace oleracea, armeniacae and mori dadicis cortex and preparation method thereof | |
JP2009179605A (en) | Melanogenesis inhibitor, and skin-lightening agent comprising the same | |
KR102291590B1 (en) | Extract of fermented red cabbage with increased uridine content and cosmetic composition containing the same, and process for producing the same | |
KR20190049067A (en) | A cosmetic composition comprising extract of coffee silver skin and coffee grounds | |
KR20160055118A (en) | Cosmetic composition comprising of the mixed herb fermentes and preparation method of the same | |
KR102606380B1 (en) | Composition for enhancing skin barrier containing Bolboschoenus planiculmis extract | |
KR102093879B1 (en) | The cosmetic composition containing root extract of Adenophora stricta for improving skin wrinkle | |
KR101796710B1 (en) | Cosmetic Composition Comprising Ribonucleic acid and Extract of Viola mandshurica as active ingredient | |
KR102489114B1 (en) | Cosmetic composition comprising fermented soymilk and manufacturing method thereof | |
US11684564B2 (en) | Cosmetic composition for improving skin containing taraxacum coreanum phytoplacenta culture extract that has moisturizing and soothing effects for extremely dry skin such as atopic dermatitis, and skin barrier strengthening effect | |
KR102450893B1 (en) | Cosmetic composition for improving skin comprising complex of exosome derived from Hydrangea Macrophylla and methods of the same | |
KR102331412B1 (en) | Composition with excellent initial improvement activitiy for skin regeneration and moisturing comprising evening primrose extracts |